Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 298761000001112 | Andexanet alfa | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 298771000001119 | Andexanet alfa (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Andexanet alfa | Is a | Coagulation factor X | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Andexanet alfa 200mg powder for solution for infusion vials | Has specific active ingredient | False | Andexanet alfa | Inferred relationship | Existential restriction modifier | |
| Ondexxya 200mg powder for solution for infusion vials (AstraZeneca UK Ltd) | Has specific active ingredient | False | Andexanet alfa | Inferred relationship | Existential restriction modifier | |
| Andexanet alfa 200mg powder for solution for infusion vials 4 vial | Has specific active ingredient | False | Andexanet alfa | Inferred relationship | Existential restriction modifier | |
| Ondexxya 200mg powder for solution for infusion vials (AstraZeneca UK Ltd) 4 vial | Has specific active ingredient | False | Andexanet alfa | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR